Patients diagnosed with stage I or II NSCLC primarily treated with stereotactic body radiation therapy (SBRT) were selected (N = 554). The PHOM score was calculated for each patient's pretreatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback